Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
10.1245/ASO.2004.03.006
Annals of Surgical Oncology 11:619-628 (2004)
© 2004 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bentz, B. G.
Right arrow Articles by Kraus, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bentz, B. G.
Right arrow Articles by Kraus, D.

ORIGINAL ARTICLES

Head and Neck Soft Tissue Sarcomas: A Multivariate Analysis of Outcomes

Brandon G. Bentz, MD, Bhuvanesh Singh, MD, James Woodruff, MD, Murray Brennan, MD, Jatin P. Shah, MD and Dennis Kraus, MD

From the Department of Surgery, Division of Otolaryngology-Head & Neck Surgery, University of Utah School of Medicine and the Huntsman Cancer Institute, Salt Lake City, Utah (BGB); Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York (BS, MB, JPS, DK); and Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York (JW).

Correspondence: Address correspondence and reprint requests to: Dennis Kraus, MD, Head & Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021; Fax: 212-717-3302; E-mail: krausd{at}mskcc.org

Background: Soft tissue sarcomas of the head and neck region represent a rare group of tumors of which a limited number of published individual- and institution-based experiences exist.

Methods: We performed an analysis of head and neck sarcoma patients identified from our institution between 1973 and 1999. Exclusion criteria included pediatric rhabdomyosarcomas, sarcomas of the neuromeningeal axis or non–head and neck primary disease sites, and bone sarcomas. All cases underwent pathologic re-review before statistical analysis.

Results: After pathologic review, 111 head and neck sarcoma patients remained (mean age, 47 ± 20 years). The median duration of follow-up was 51 months; the actuarial 5-year relapse-free, disease-specific, and overall survivals were 55%, 52%, and 44%, respectively. Forty-six percent remained free of recurrence at the most recent follow-up, and the most common site of recurrence was local followed by distant sites. By multivariate analysis, size and grade significantly influenced relapse-free, disease-specific, and overall survivals, whereas margin status additionally influenced relapse-free survival. Subset analysis of the fibrosarcoma/malignant fibrous histiocytoma and desmoid/dermatofibrosarcoma protuberans histologies was undertaken.

Conclusions: Size >5 cm and high-grade histology are considered poor prognostic indicators. Patients with either of these characteristics should be considered for adjuvant trials.

Key Words: Head and neck • Sarcoma • Multivariate analysis • Retrospective • Single institution






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society of Surgical Oncology.